RADNOR, Pa., June 6, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it has entered into definitive agreements for the purchase and sale of 9,670,002 shares of common…
News Ticker
- [ September 30, 2023 ] Senior Manager, Patient Marketing – Mitsubishi Tanabe Pharma – Jersey City, NJ Jobs
- [ September 29, 2023 ] Scientist, Analytical Strategy & Operations – Spectrix Analytical Services, LLC – New Brunswick, NJ Jobs
- [ September 29, 2023 ] Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting News
- [ September 29, 2023 ] Gene therapy startup Lexeo files to go public in shrinking window for IPOs before Thanksgiving News
- [ September 29, 2023 ] KVK-Tech, Inc. Issues Voluntary Nationwide Recall of one lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a precautionary measure due to a single foreign tablet found during the line clearance after the batch was packaged News
Copyright © 2023 Biotech Networks, LLC
Be the first to comment